$2.67 -0.12 (-4.30%) OncoGenex Pharmaceuticals Inc - NASDAQ

Sep. 30, 2014 | 02:38 PM
Key Statistics
Last Trade: 2.67
Trade Time: Sep 30 02:38 PM Eastern Daylight Time
Change: -0.12 (-4.30%)
Prev Close: 2.79
Open: 2.80
Bid: 2.67
Ask: 2.68

Competitors

Ticker Name Volume % Change
CLDX Celldex Therapeutics Inc 2.60M -4.60%
IMMU Immunomedics Inc 1.77M +9.09%
LPDX LipoScience Inc 1.24M -0.10%
NAVB Navidea Biopharmaceuticals Inc 592.02K +4.72%
MYGN Myriad Genetics Inc 562.93K +2.59%

OGXI Stock Analysis

Partner Headlines

  1. OncoGenex Announces Update on Phase 3 ENSPIRIT Trial Evaluating Custirsen in Advanced ...

    Benzinga | Aug. 21, 2014 | 16:02PM EST
  2. Stocks Hitting 52-Week Lows

    Benzinga | Jul. 29, 2014 | 10:26AM EST
  3. Morning Market Losers

    Benzinga | Apr. 28, 2014 | 09:51AM EST
  4. Benzinga's Top #PreMarket Losers

    Benzinga | Apr. 28, 2014 | 08:09AM EST
  5. UPDATE: Teva, Oncogenex Offer Top-Line Survival Results of Phase III SYNERGY Trial ...

    Benzinga | Apr. 28, 2014 | 07:21AM EST
  6. UPDATE: CRT Capital Initiates Coverage on OncoGenex

    Benzinga | Feb. 27, 2014 | 11:06AM EST